Acetyl chloride → HCID 59716924, compound
Reaction equation
[F:1][C:2]([F:36])([F:35])[C:3]1[CH:34]=[CH:33][C:6]([CH2:7][N:8]2[C:31](=[O:32])[N:11]3[NH:12][CH:13]([CH3:30])[C:14]([C:23]4[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][CH:24]=4)=[C:15]([C:16]4[CH:21]=[CH:20][C:19]([Cl:22])=[CH:18][CH:17]=4)[C:10]3=[N:9]2)=[CH:5][CH:4]=1.C(N(C(C)C)CC)(C)C.[C:46](Cl)(=[O:48])[CH3:47]>C(Cl)Cl>[F:36][C:2]([F:35])([F:1])[C:3]1[CH:4]=[CH:5][C:6]([CH2:7][N:8]2[C:31](=[O:32])[N:11]3[N:12]([C:46](=[O:48])[CH3:47])[CH:13]([CH3:30])[C:14]([C:23]4[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][CH:24]=4)=[C:15]([C:16]4[CH:17]=[CH:18][C:19]([Cl:22])=[CH:20][CH:21]=4)[C:10]3=[N:9]2)=[CH:33][CH:34]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 2-(4-(trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one (8 mg, 0.015 mmol), prepared as described in Example 469 in CH2Cl2 (0.2 mL) at RT was added diisopropyl ethyl amine (5.8 mg, 0.045 mmol), followed by acetyl chloride (2.4 mg, 0.030 mmol). The reaction was stirred at RT for 2 h. LC-MS showed the completion of the reaction. The solvent was evaporated and the residue was purified using reverse phase HPLC to give the title compound, 2-(4-(Trifluoromethyl)benzyl)-5-acetyl-7,8-bis(4-chlorophenyl)-6-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one, (6 mg, 70%) as a white solid. HPLC retention time: 4.23 min; MS [M+H]+: found 573. 1H NMR (CDCl3, 400 MHz) δ 7.65 (d, 2H), 7.51 (d, 2H), 7.30-7.22 (m, 4H), 7.17 (dd, 2H), 7.06 (dd, 2H), 5.70 (q, 1H), 5.14-5.11 (m, 2H), 2.28 (s, 3H), 1.28 (s, 3H).
Workup
- customthe completion of the reaction
- customThe solvent was evaporated
- customthe residue was purified
Sources & evidence
- ORD record
- ord-000289a43a57460f9aac54a14ab0281a
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07378418B2
Reaction notes
Loading…